STOCK TITAN

Guardian Pharmacy officer proposes $989K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Guardian Pharmacy Services, Inc. (GRDN) officer David Martin reported a proposed sale of 20,000 common shares, with an aggregate market value of $988,600 and an approximate sale date of November 17, 2026. The shares were acquired from the issuer via M&A on September 26, 2024.

Proposed sale shares 20,000 shares Guardian Pharmacy Services common shares; approximate sale date November 17, 2026
Aggregate market value $988,600 Proposed sale of 20,000 common shares
Shares outstanding 63,320,300 shares Number stated in the securities information
Approximate sale date November 17, 2026 Proposed sale
Rule 10b5-1 regulatory
"If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
M&A financial
"Acquired via M&A"
M&A, short for mergers and acquisitions, involves one company combining with or purchasing another company to grow, streamline operations, or gain competitive advantages. For investors, M&A activity can signal potential for increased value, new opportunities, or changes in market dynamics, making it an important factor to watch in the business landscape.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GRDN shares did David Martin propose to sell?

David Martin, an officer of Guardian Pharmacy Services, Inc., reported a proposed sale of 20,000 common shares, with an aggregate market value of $988,600 and an approximate sale date of November 17, 2026.

What date does the GRDN notice list for David Martin’s Rule 10b5-1 plan?

The notice lists August 18, 2026 as the plan adoption or instruction date, if relying on Rule 10b5-1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading